Skip to main content
Clinical Trials/NCT01187342
NCT01187342
Completed
Not Applicable

Depression and Posttraumatic Stress Disorder in Stroke Patients: an Observational Study of Neuro-psychiatric, Cognitive, and MR-Changes Over Time After Stroke

Charite University, Berlin, Germany1 site in 1 country84 target enrollmentOctober 2009
ConditionsStroke

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stroke
Sponsor
Charite University, Berlin, Germany
Enrollment
84
Locations
1
Primary Endpoint
occurence of depression (GDS, SKID)
Status
Completed
Last Updated
last year

Overview

Brief Summary

Neuro-psychological, cognitive and biochemical assessment matched with MR-Imaging in acute and chronic poststroke conditions.

Detailed Description

The study design relates to affective symptomatology, particularly poststroke depression and posttraumatic stress symptoms as well as to cognitive decline due to stress-related hypercortisolemia in the early phase after stroke. Extended MRI studies including a functional connectivity (fc-MRI) paradigm have been incorporated to study on subacute midbrain neurodegeneration as a possible morphological correlate of functional and clinical findings.

Registry
clinicaltrials.gov
Start Date
October 2009
End Date
January 2015
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Matthias Endres

Prof. MD

Charite University, Berlin, Germany

Eligibility Criteria

Inclusion Criteria

  • Stroke in MCA/AchA territory of striato-capsular (at least 125mm³) or non-striatal (10-100cm³) involvement
  • MR-imaging can be conducted 24-48 hours of onset
  • preserved communication skills

Exclusion Criteria

  • Patients with psychiatric conditions or medication in the last 4 weeks
  • severe medical conditions
  • limited prognosis

Outcomes

Primary Outcomes

occurence of depression (GDS, SKID)

Time Frame: 90 days

Geriatric Depression Scale, Structured Clinical interview for DSM-IV

Secondary Outcomes

  • change in serumcholine(90days)
  • change in saliva cortisol(90days)

Study Sites (1)

Loading locations...

Similar Trials